Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC), investigating whether we can […]
Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs On the 24th and 25th July 2023, JDRF Australia was delighted to host a research symposium: T1Decade of Research Progress – Past & Future to commemorate over a decade of achievements of the Type 1 Diabetes Clinical Research Network (T1DCRN). The T1DCRN is […]
JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute. The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to […]
JDRF Australia is excited to announce our partnership with Cicada Innovations, leaders in deep tech incubation to accelerate scientific progress and bridge translation gaps. Our partnership will accelerate type 1 diabetes (T1D) research translation and commercialisation through providing resources, mentorship, funding, and networking opportunities. Our goal is to bring scientific discoveries into real-world solutions for […]
A new study has shown drug Verapamil, regularly used to treat blood pressure, can slow type 1 diabetes progression in newly diagnosed children and teens. As researchers work to cure type 1 diabetes (T1D), the ultimate goal is to prevent the destruction of beta cells that produce insulin. A new JDRF-funded clinical trial reveals a […]
MEDIA RELEASE Australia leading type 1 diabetes research with $12M invested to progress landmark study The funding will support the extension of ENDIA, a world-first study seeking to understand the role of environmental triggers from as early as pregnancy for the onset of type 1 diabetes (T1D). 4 April 2023: JDRF Australia and funding partner […]
“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D” Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D). As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection […]
We sat down with Dr Aveni Haynes to hear from a woman in STEM who inspires in the world of type 1 diabetes (T1D). What drew you to a career in T1D research? “While training to become a doctor, I was fascinated by the complexity and ingenuity of the human body and to date I […]
The T1D Index is a first-of-its-kind data simulation tool that measures the human and public health impact of the T1D crisis in every country across the globe.
Eye damage in people living with type 1 diabetes (T1D) People living with T1D are 25 times more likely to develop vision loss than those living without the condition. The strict control of blood glucose levels necessary for the prevention of diabetic eye disease (retinopathy) is often difficult to achieve. Further, even if blood glucose […]
One key area of research for slowing and preventing the onset of type 1 diabetes (T1D) is understanding how to stop the immune system from attacking and destroying the cells in the pancreas that produce insulin. What is the IMPACT Trial? A new JDRF-funded study, known as the IMPACT trial, is testing if a new […]
Three Australian children are diagnosed with type 1 diabetes (T1D) every day, and of those, one-third are not diagnosed until they require emergency medical care. Screening for T1D at a population level is therefore essential for detecting a majority of the children at risk of diagnosis. In July 2022, the Type 1 Diabetes National Screening […]
JDRF has an ambitious vision — a world without type 1 diabetes (T1D). We are the biggest funder of type 1 diabetes research globally and in Australia. In order to achieve this with such a complex autoimmune disease, we must take a strategic, multi-level and collaborative approach to research. JDRF has embarked on an extensive […]
Dr Izzy Smith specialises in endocrinology and we spoke to her for some guidance on Covid-19 for people living with type 1 diabetes.
This week, new results published in the journal Microbiome showed that a six-week food supplement for people with T1D resulted in changes to bacteria in the gut and a strengthened immune system. The results are from a clinical trial funded through JDRF’s Type 1 Diabetes Clinical Research Network (T1DCRN) and Macquarie Group Foundation Future Research […]
An analysis of the impact of the Australian Government’s continuous glucose monitoring (CGM) subsidy scheme for people aged under 21 has recently been published in the journal Diabetes Care. Led by Prof Tim Jones and the Australasian Diabetes Data Network (ADDN) Study Group, the study found that those who registered for the subsidy had significant […]
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Exciting results from clinical trials […]